Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131596 | 1.00 | CA1 (0.41) | CA1CA2CA9APLNR | |
| SCHEMBL1115357 | 0.69 | — | — | |
| SCHEMBL2864770 | 0.69 | — | — | |
| SCHEMBL43258 | 0.68 | — | — | |
| SCHEMBL1785369 | 0.67 | MEN1 (0.30) | — | |
| SCHEMBL8083316 | 0.65 | — | — | |
| Bromide SCHEMBL30609919 | 0.65 | — | — | |
| SCHEMBL2129023 | 0.65 | — | — | |
| SCHEMBL9710368 | 0.65 | CA2 (0.44) | CA1CA2CA9APLNR | |
| Iodide SCHEMBL28619013 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158466-A1 | PEGYLATED P-SELECTIN INHIBITORS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2024-05-16 | — | — | US | disclosed |
| US-20210147598-A1 | FUNCTIONAL OLIGOMERS AND FUNCTIONAL POLYMERS INCLUDING HYDROXYLATED POLYMERS AND CONJUGATES THEREOF AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147598-A1 | FUNCTIONAL OLIGOMERS AND FUNCTIONAL POLYMERS INCLUDING HYDROXYLATED POLYMERS AND CONJUGATES THEREOF AND USES THEREOF | PUF60, PGLS, PARG | CA1 2704/4885CA2 4147/4885CA9 2925/4885 |
| US-20240158466-A1 | PEGYLATED P-SELECTIN INHIBITORS | SELP, SELE, SELPLG | CA1 3038/4885CA2 4572/4885CA9 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.